Analytical Data
-
基因名
EGR3
- Application
-
别名
PILOT; Zinc Finger Protein Pilot
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q06889
-
表达区间
Cys98~Ala363
-
分子量
40kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EGR3 (Early Growth Response 3) is a pivotal transcription factor involved in various cellular processes, including growth, differentiation, and response to environmental stimuli. As a member of the EGR family, EGR3 is characterized by its zinc finger domains that facilitate DNA binding and regulation of gene expression. Research has increasingly focused on EGR3 due to its role in neuronal function, immunological responses, and its potential involvement in various diseases, including cancer and neurodegenerative disorders. The study of recombinant EGR3 protein provides valuable insights into its structural properties, functional mechanisms, and interactions with other cellular factors. By generating and purifying EGR3 in a recombinant form, scientists can examine its biochemical characteristics, explore its role in transcriptional regulation, and assess the impact of specific mutations on its activity. Moreover, understanding the signaling pathways mediated by EGR3 and its target genes can unveil therapeutic targets for diseases associated with dysregulated EGR3 expression. This growing body of research highlights the importance of recombinant EGR3 protein as a tool for dissecting its biological functions and paving the way for potential medical applications.
